Palabras clave
neutropenia
G-CSF
Cómo citar
Resumen
Mirtazapina es un antidepresivo de uso común y que estimula el apetito. A pesar de que en estudios precomercialización la incidencia de neutropenia inducida por mirtazapina fue de 1.1/1000, la literatura sobre este tema es escasa.
Citas
Jilani TN, Gibbons JR, Faizy RM, Saadabadi A. Mirtazapine. In: StatPearls. StatPearls Publishing; 2023. Accessed March 31, 2023. http://www.ncbi.nlm.nih.gov/books/NBK519059/
Remeron (mirtazapine) tablets.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
Approach to the adult with unexplained neutropenia - UpToDate. Accessed March 31, 2023. https://www.uptodate.com/contents/approach-to-the-adult-with-unexplained-neutropenia
Song Mingqiao, Sun Dan. A case of leukopenia caused y the combination of mirtazapine and olanzapine. Chinese Modern Drug Application. 2012;6(22):92-93.
Mirtazapine: seizures and neutropenia. Prescrire Int. 2004;13(70):58.
Mutlu OA, Kavla Y, Demirel ÖF. Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine. J Clin Psychopharmacol. 2022;42(1):107-109. doi:10.1097/JCP.0000000000001482
Dholakia R, Schleifer SJ, Ahmad YJ, Narang IS. Delayed-Onset Mirtazapine-Related Leukopenia and Rechallenge. Journal of Clinical Psychopharmacology. 2010;30(6):758. doi:10.1097/JCP.0b013e3181faa564
Khan AY, Golewale MH, Kahn DA. A Case of Chronic Drug-Induced Neutropenia. Journal of Psychiatric Practice. 2008;14(4):246-250. doi:10.1097/01.pra.0000327316.27023.5d
Ahmed A. Neutropenia Associated with Mirtazapine Use: Is a Drop in the Neutrophil Count in a symptomatic Older Adults a Cause for Concern? Journal of the American Geriatrics Society. 2002;50(8):1461-1463.doi:10.1046/j.1532-5415.2002.50375.x
Depression, medication, and ‘bad blood.’ Accessed March 31, 2023. https://www.mdedge.com/psychiatry/article/62671/depression-medication-and-bad-blood
Toprak S, Erdoğan E, Azap O. Mirtazapine-Induced Thrombocytopenia and Neutropenia. Turkish Journal of Hematology. 2012;29:297-298. doi:10.5505/tjh.2012.72325
Anghelescu I. Venlafaxine in a Patient With Idiopathic Leukopenia and Mirtazapine-Induced Severe Neutropenia. J Clin Psychiatry. 2002;63(9):22172.
Nazer LH, Shankar G, Ali BAH, Al-Najjar T. Fatal agranulocytosis associated with psychotropic medication use. American Journal of Health-System Pharmacy. 2012;69(10):863-867. doi:10.2146/ajhp110195
Walder A, Baumann P. Cardiac Left Bundle Branch Block and Pancytopenia in Anorexia Nervosa: Higher Risk with Mirtazapine and Pantoprazole? Case Report. Pharmacopsychiatry. 2009;42(2):79-81.doi:10.1055/s-0028-1103290
Ozcanli T, Unsalver B, Ozdemir S, Ozmen M. Sertraline-and Mirtazapine-Induced Severe Neutropenia. AJP. 2005;162(7):1386-1386. doi:10.1176/appi. ajp.162.7.1386
Civalier KA, Krahn LE, Agrwal N. Repeated Episodes of Neutropenia Triggered by Mirtazapine. Psychosomatics. 2009;50(3):299-300. doi:10.1176/appi.psy.50.3.299
Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. J Gen Intern Med. 2022;37(Suppl 2):129-664. doi:10.1007/s11606-022-07653-8
Biswas PN, Wilton LV, Shakir SAW. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in England. J Psychopharmacol. 2003;17(1):121-126. doi:10.1177/0269881103017001716
Huber M, Andersohn F, Bronder E, et al. Drug-induced agranulocytosis in the Berlin case–control surveillance study. Eur J Clin Pharmacol. 2014;70(3):339-345. doi:10.1007/s00228-013-1618-1
Andrès E, Mourot-Cottet R, Maloisel F, et al. Idiosyncratic drug-induced neutropenia & agranulocytosis. QJM. Published online January 9, 2017:hcw220. doi:10.1093/qjmed/hcw220
Almishri W, Davis RP, Shaheen AA, Altonsy MO, Jenne CN, Swain MG. The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the Mouse. Frontiers in Immunology. 2021;12. Accessed April 1, 2023. https://www.frontiersin.org/articles/10.3389/fimmu.2021.622537
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.154
Curtis BR. Non–chemotherapy drug–induced neutropenia: key points to manage the challenges. Hematology. 2017;2017(1):187-193. doi:10.1182/asheducation-2017.1.187
Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Metab Toxicol. 2015;11(2):243-257. doi:10.1517/17425255.2015.985649
Uetrecht J, Naisbitt DJ. Idiosyncratic Adverse Drug Reactions: Current Concepts. Pharmacol Rev. 2013;65(2):779-808. doi:10.1124/pr.113.007450
[A case of allergic cross reaction between tricyclic antidepressants and maprotiline]. | Sigma-Aldrich. Accessed April 1, 2023. https://www.sigmaaldrich.com/US/en/tech-docs/paper/381427
Fukata S, Kuma K, Sugawara M. Granulocyte colony- stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid. 1999;9(1):29-31. doi:10.1089/thy.1999.9.29
Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146(9):657-665. doi:10.7326/0003-4819-146-9-200705010-00009
Todo el material publicado en la revista Hematología (versión electrónica y versión impresa), será cedido a la Sociedad Argentina de Hematología. De conformidad con la ley de derecho de autor (ley 11723) se les enviara a los autores de cada trabajo aceptado formulario de cesión de derechos de autor que deberá ser firmado por todos los autores antes de la publicación. Los autores deberán retener una copia del original pues la revista, no acepta responsabilidad por daños o pérdidas del material enviado. Los autores deberán remitir una versión electrónica al correo: revista@sah.org.ar